Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
31,522,645
-
Total 13F shares
-
1,412,361
-
Share change
-
+1,412,344
-
Total reported value
-
$16,863,937
-
Price per share
-
$11.94
-
Number of holders
-
25
-
Value change
-
+$16,863,732
-
Number of buys
-
24
Institutional Holders of Cidara Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CDTX) as of Q2 2024
As of 30 Jun 2024,
Cidara Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CDTX) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,412,361 shares.
The largest 10 holders included
Monashee Investment Management LLC, BVF INC/IL, VANGUARD GROUP INC, Checkpoint Capital L.P., RENAISSANCE TECHNOLOGIES LLC, ALETHEA CAPITAL MANAGEMENT, LLC, 5AM Venture Management, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, and Schonfeld Strategic Advisors LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.